<DOC>
	<DOC>NCT00106392</DOC>
	<brief_summary>The purpose of the study is to compare the safety and effectiveness of Prograf in the prevention of erectile dysfunction in men after a radical prostatectomy.</brief_summary>
	<brief_title>A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy</brief_title>
	<detailed_description>The purpose of the study is to compare the safety and efficacy of Prograf versus placebo in the prevention of erectile dysfunction in men after a bilateral nerve-sparing radical prostatectomy.</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Male scheduled to undergo bilateral nerve sparing radical prostatectomy for prostate cancer. Patient is &gt; 65 years of age Patient has been diagnosed with Type 1 or Type 2 diabetes Patient is actively smoking on a daily basis</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Treatment effectiveness</keyword>
	<keyword>Treatment efficacy</keyword>
	<keyword>Investigational, Therapies</keyword>
	<keyword>Immunosuppressant</keyword>
	<keyword>Erectile dysfunction</keyword>
	<keyword>Prostatectomy</keyword>
</DOC>